Bert Vander Cruyssen
- Rheumatology top 0.5%
- Immunology top 5%
- Genetics top 10%
- Hematology top 5%
- Surgery top 10%
- Co-authors
- Dirk ElewautGust VerbruggenRuth WittoekNathan VastesaegerFilip De KeyserEduardo Collantes‐EstévezHerman MielantsFilip Van den Bosch
- Topics
- Rheumatoid Arthritis Research and Therapies (37 papers)Spondyloarthritis Studies and Treatments (19 papers)Systemic Lupus Erythematosus Research (16 papers)
- Cited by
- RheumatologyImmunologyHematology
- Partner nations
- BelgiumNetherlandsSpain
In The Last Decade
Bert Vander Cruyssen
55 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 107
- Rheumatology 1.4k
- Immunology 615
- Genetics 334
- Hematology 320
- Surgery 281
Countries citing papers authored by Bert Vander Cruyssen
This map shows the geographic impact of Bert Vander Cruyssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Vander Cruyssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Vander Cruyssen more than expected).
Fields of papers citing papers by Bert Vander Cruyssen
This network shows the impact of papers produced by Bert Vander Cruyssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Vander Cruyssen. The network helps show where Bert Vander Cruyssen may publish in the future.
Co-authorship network of co-authors of Bert Vander Cruyssen
This figure shows the co-authorship network connecting the top 25 collaborators of Bert Vander Cruyssen. A scholar is included among the top collaborators of Bert Vander Cruyssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert Vander Cruyssen. Bert Vander Cruyssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 20 | |
| 4 | Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab. | 7 |
| 5 | 125 | |
| 6 | 3 | |
| 7 | 17 | |
| 8 | A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration: the Be-Raise study | 1 |
| 9 | 49 | |
| 10 | 25 | |
| 11 | 139 | |
| 12 | Xylosan polysulphate as a symptom modifying osteoarthritis drug in patients with finger joint arthritis | 1 |
| 13 | 15 | |
| 14 | 49 | |
| 15 | 32 | |
| 16 | Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Attrition and long-term clinical effect | 1 |
| 17 | 2 | |
| 18 | Potent anti-inflammatory, fully dissociative compound for glucocorticoid receptor-mediated gene regulation | 2 |
| 19 | Comparing statistics with machine learning models to predict dose increase of infliximab for rheumatoid arthritis patients | 1 |
| 20 | Comparison of Machine Learning models for prediction of dose increase in patients with rheumatoid arthritis | 3 |
About Bert Vander Cruyssen
Bert Vander Cruyssen is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 61 papers that have together received 2.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (37 papers), Spondyloarthritis Studies and Treatments (19 papers) and Systemic Lupus Erythematosus Research (16 papers). The work is most often cited by research in Rheumatology (1.4k citations), Immunology (615 citations) and Hematology (320 citations). Bert Vander Cruyssen has collaborated with scholars based in Belgium, Netherlands and Spain. Frequent co-authors include Dirk Elewaut, Gust Verbruggen, Ruth Wittoek, Nathan Vastesaeger, Filip De Keyser, Eduardo Collantes‐Estévez, Herman Mielants, Filip Van den Bosch, Kurt De Vlam and Dieter Deforce. Their work appears in journals such as The EMBO Journal, The Journal of Immunology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.